559 related articles for article (PubMed ID: 11943125)
1. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
Urschel JD; Vasan H; Blewett CJ
Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.
Urschel JD; Vasan H
Am J Surg; 2003 Jun; 185(6):538-43. PubMed ID: 12781882
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for resectable esophageal carcinoma: a meta-analysis of randomized clinical trials.
Xu XH; Peng XH; Yu P; Xu XY; Cai EH; Guo P; Li K
Asian Pac J Cancer Prev; 2012; 13(1):103-10. PubMed ID: 22502650
[TBL] [Abstract][Full Text] [Related]
4. Handsewn or stapled esophagogastric anastomoses after esophagectomy for cancer: meta-analysis of randomized controlled trials.
Urschel JD; Blewett CJ; Bennett WF; Miller JD; Young JE
Dis Esophagus; 2001; 14(3-4):212-7. PubMed ID: 11869322
[TBL] [Abstract][Full Text] [Related]
5. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.
Lv J; Cao XF; Zhu B; Ji L; Tao L; Wang DD
World J Gastroenterol; 2009 Oct; 15(39):4962-8. PubMed ID: 19842230
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Esophageal Cancer Patients: A Systematic Review and Meta-Analysis.
Xiao X; Hong HG; Zeng X; Yang YS; Luan SY; Li Y; Chen LQ; Yuan Y
World J Surg; 2020 Dec; 44(12):4161-4174. PubMed ID: 32761259
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2003; (4):CD001556. PubMed ID: 14583936
[TBL] [Abstract][Full Text] [Related]
9. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
11. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.
Jin HL; Zhu H; Ling TS; Zhang HJ; Shi RH
World J Gastroenterol; 2009 Dec; 15(47):5983-91. PubMed ID: 20014464
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Kidane B; Coughlin S; Vogt K; Malthaner R
Cochrane Database Syst Rev; 2015 May; 2015(5):CD001556. PubMed ID: 25988291
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of randomized controlled trials of route of reconstruction after esophagectomy for cancer.
Urschel JD; Urschel DM; Miller JD; Bennett WF; Young JE
Am J Surg; 2001 Nov; 182(5):470-5. PubMed ID: 11754853
[TBL] [Abstract][Full Text] [Related]
18. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus.
Rebecca WO; Richard MA
Cochrane Database Syst Rev; 2003; (1):CD002092. PubMed ID: 12535428
[TBL] [Abstract][Full Text] [Related]
19. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus.
Wong R; Malthaner R
Cochrane Database Syst Rev; 2001; (2):CD002092. PubMed ID: 11406033
[TBL] [Abstract][Full Text] [Related]
20. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
Pasquali S; Yim G; Vohra RS; Mocellin S; Nyanhongo D; Marriott P; Geh JI; Griffiths EA
Ann Surg; 2017 Mar; 265(3):481-491. PubMed ID: 27429017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
